Benjamin Burnett
Stock Analyst at Wells Fargo
(2.75)
# 2,758
Out of 4,455 analysts
371
Total ratings
44.9%
Success rate
1.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECX Tectonic Therapeutic | Rated: Buy | $101 | $31.99 | +215.72% | 3 | Jun 12, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $255 | $241.67 | +5.52% | 7 | Jun 10, 2026 | |
| ALKS Alkermes | Maintained: Buy | $44 | $55.08 | -20.12% | 10 | Jun 8, 2026 | |
| INSM Insmed | Maintained: Buy | $160 | $103.38 | +54.77% | 7 | Jun 4, 2026 | |
| LQDA Liquidia | Maintained: Buy | $62 | $78.17 | -20.69% | 5 | Jun 4, 2026 | |
| MNKD MannKind | Maintained: Buy | $11 | $4.14 | +165.70% | 6 | Jun 2, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $69 | $59.74 | +15.50% | 10 | Jun 1, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Hold | $305 → $323 | $327.79 | -1.46% | 5 | Jun 1, 2026 | |
| SVRA Savara | Rated: Buy | $9 | $5.90 | +52.54% | 5 | May 22, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $13 → $14 | $5.83 | +140.14% | 7 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $10.99 | +81.98% | 4 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $21.78 | -12.76% | 1 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $575 → $738 | $542.66 | +36.00% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $47 | $30.77 | +52.75% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $40.06 | +14.83% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 | $84.43 | +1.86% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $64 | $182.08 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $13 | $3.04 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.86 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $4.25 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $2.13 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $10.39 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $2.10 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $92 | $74.78 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $0.341 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $49 | $54.92 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $64 | $36.74 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0006 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $7.29 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.7 → $3 | $63.65 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $32.03 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.0001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $34.81 | n/a | 2 | Feb 28, 2022 |
Tectonic Therapeutic
Jun 12, 2026
Rated: Buy
Price Target: $101
Current: $31.99
Upside: +215.72%
Axsome Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: $255
Current: $241.67
Upside: +5.52%
Alkermes
Jun 8, 2026
Maintained: Buy
Price Target: $44
Current: $55.08
Upside: -20.12%
Insmed
Jun 4, 2026
Maintained: Buy
Price Target: $160
Current: $103.38
Upside: +54.77%
Liquidia
Jun 4, 2026
Maintained: Buy
Price Target: $62
Current: $78.17
Upside: -20.69%
MannKind
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $4.14
Upside: +165.70%
Xenon Pharmaceuticals
Jun 1, 2026
Maintained: Buy
Price Target: $69
Current: $59.74
Upside: +15.50%
Praxis Precision Medicines
Jun 1, 2026
Maintained: Hold
Price Target: $305 → $323
Current: $327.79
Upside: -1.46%
Savara
May 22, 2026
Rated: Buy
Price Target: $9
Current: $5.90
Upside: +52.54%
Wave Life Sciences
May 20, 2026
Rated: Buy
Price Target: $13 → $14
Current: $5.83
Upside: +140.14%
May 15, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $10.99
Upside: +81.98%
May 14, 2026
Downgraded: Hold
Price Target: $19
Current: $21.78
Upside: -12.76%
May 7, 2026
Upgraded: Buy
Price Target: $575 → $738
Current: $542.66
Upside: +36.00%
May 6, 2026
Maintained: Buy
Price Target: $45 → $47
Current: $30.77
Upside: +52.75%
Apr 22, 2026
Maintained: Buy
Price Target: $46
Current: $40.06
Upside: +14.83%
Apr 13, 2026
Maintained: Buy
Price Target: $86
Current: $84.43
Upside: +1.86%
Apr 1, 2025
Maintained: Buy
Price Target: $78 → $64
Current: $182.08
Upside: n/a
Mar 31, 2025
Maintained: Buy
Price Target: $26 → $13
Current: $3.04
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $5.86
Upside: n/a
Mar 17, 2025
Maintained: Buy
Price Target: $18
Current: $4.25
Upside: n/a
Mar 17, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $2.13
Upside: n/a
Mar 11, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $10.39
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $2.10
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $94 → $92
Current: $74.78
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $80
Current: $0.341
Upside: n/a
Feb 13, 2025
Maintained: Hold
Price Target: $53 → $49
Current: $54.92
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $66 → $64
Current: $36.74
Upside: n/a
Apr 19, 2024
Maintained: Buy
Price Target: $10
Current: $0.0006
Upside: n/a
Aug 16, 2023
Maintained: Buy
Price Target: $42
Current: $7.29
Upside: n/a
Mar 2, 2023
Maintained: Hold
Price Target: $4.7 → $3
Current: $63.65
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $32.03
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.0001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $34.81
Upside: n/a